|
|
发表于 2009-4-30 05:10 PM
|
显示全部楼层
作假报告
http://www.businesswire.com/port ... 436&newsLang=en
"SAN DIEGO--(BUSINESS WIRE)--The law firm of Johnson Bottini, LLP is reviewing potential securities law violations by Sequenom, Inc. (NASDAQ:SQNM). If you purchased Sequenom stock or securities between June 4, 2008 and April 29, 2009 and have suffered losses, you may have a claim for damages due to potential violations of the federal securities laws by executives at the Company.
On April 29, 2009, after the market closed, Sequenom announced that the expected launch of its SEQureDxTM Down syndrome test will be delayed because of employee mishandling of SEQureDx test data and results. As a result, in after-market trading, Sequenom stock lost more than two-thirds of its trading value, falling from $14.91 to $4.69. The Company has promoted SEQureDx as a prenatal test to screen for Down syndrome. Now, however, due to the mishandling of test results by Sequenom employees, the Company has stated that “the company is no longer relying on the previously announced R&D test data and results” and that any commercial launch of SEQureDxTM will be delayed for an unknown period of time. In fact, the Company has hired a team of lawyers to conduct an “independent investigation” of the wrongdoing on behalf of a “Special Committee” of the Company’s Board of Directors. Moreover, the Company announced on April 29, 2009 that it will now review the test results and data for all its products, not just SEQureDxTM. The Company’s announcement states that multiple prior press releases and public statements concerning SEQureDxTM can no longer be relied upon, including press releases the Company issued on June 4, 2008, September 23, 2008, December 1, 2008, January 28, 2009, and February 3, 2009."
(...) |
|
狗仔卡
提升卡
置顶卡
沉默卡
喧嚣卡
变色卡
因为俺是INSIDER嘿嘿
